Antibody-drug conjugates (ADCs): a novel therapy for triple-negative breast cancer (TNBC)

Curr Cancer Drug Targets. 2024 Sep 7. doi: 10.2174/0115680096343056240828190900. Online ahead of print.

¹ Chitkara College of Pharmacy, Chitkara University, Rajpura, Chandigarh, India.
² Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
³ Uttaranchal University Uttaranchal Institute of Pharmaceutical Sciences Dehradun India.
⁴ Graphic Era Hill University School of Pharmaceutical Sciences Dehradun India.
⁵ Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University Centre for Global Health Research Chennai India.

Abstract

NA.

Keywords: Antibody-drug conjugates; Clinical trial.; Sacituzumab govitecan; Triple-negative breast cancer; Trop-2 antigen.